Cerebrospinal Fluid Markers in Dementia With Lewy Bodies Compared With Alzheimer Disease

Abstract

The tau levels in CSF may contribute to the clinical distinction between AD and DLB. Beta-amyloid CSF levels are similar in both dementia disorders and reflect disease progression better than tau levels. Interleukin CSF concentrations do not distinguish between AD and DLB.